Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00818012 · ClinicalTrials.gov registry record
Atrial Electromechanical Interval and Pulse Wave Velocity in the Prediction of Recurrence of Atrial Fibrillation
A clinical trial, sponsored by Creighton University.
- Completed
- Registry status
- 129
- Enrollment target
NCT00818012 is a clinical trial that has completed, run by Creighton University. The registered enrollment target is 129 participants.
The verdict
NCT00818012 has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- 129 participants
- Enrollment target
Study Summary
This study aims to evaluate the utility of the atrial electromechanical interval and pulse wave velocity in the prediction of recurrence of atrial fibrillation among patients who underwent successful direct current cardioversion for atrial fibrillation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2008-08 |
| Est. Completion | 2013-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00818012
The ClinicalTrials.gov registry entry for NCT00818012 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00818012 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00818012 about?
NCT00818012 is a clinical study titled "Atrial Electromechanical Interval and Pulse Wave Velocity in the Prediction of Recurrence of Atrial Fibrillation". This study aims to evaluate the utility of the atrial electromechanical interval and pulse wave velocity in the prediction of recurrence of atrial fibrillation among patients who underwent successful direct current cardioversion for atrial fibrillation.
What is the current status of trial NCT00818012?
This trial is currently completed. The enrollment target is 129 participants. The study started on 2008-08. Estimated completion is 2013-06.
Who is sponsoring clinical trial NCT00818012?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.